S&P 500 Futures
(0.19%) 5 532.25 points
Dow Jones Futures
(0.14%) 39 524 points
Nasdaq Futures
(0.18%) 19 964 points
Oil
(0.75%) $82.15
Gas
(-0.92%) $2.58
Gold
(-0.19%) $2 335.10
Silver
(-0.45%) $29.11
Platinum
(-0.58%) $1 008.20
USD/EUR
(-0.34%) $0.930
USD/NOK
(-0.47%) $10.63
USD/GBP
(-0.13%) $0.790
USD/RUB
(1.51%) $87.02

リアルタイムの更新: Opthea Ltd [OPT.AX]

取引所: ASX 産業: Pharmaceuticals, Biotechnology & Life Sciences
最終更新日時1 7月 2024 @ 15:10

-1.43% $ 0.345

Live Chart Being Loaded With Signals

Commentary (1 7月 2024 @ 15:10):
Our systems believe the stock currently is undervalued by 1.43% compare to its pairs and should correct upwards.

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage...

Stats
本日の出来高 666 437
平均出来高 1.38M
時価総額 416.10M
EPS $-0.250 ( Q2 | 2023-12-31 )
次の収益日 ( $0 ) 2024-08-28
Last Dividend $0.111 ( 2004-10-11 )
Next Dividend $0 ( N/A )
P/E -0.820
(Sector) 0
(Industry) 0
ATR14 $0.00300 (0.86%)
ACW.AX 4.84%
ADO.AX 5.00%
AGH.AX 4.35%
ANP.AX -4.92%
ATH.AX 25.00%
AVE.AX -33.33%
BIT.AX 2.63%
BNO.AX -10.00%
BOT.AX -8.70%
CAN.AX 7.14%
CPH.AX 0.00%
CSL.AX -0.88%
CTE.AX 0.81%
CUV.AX -0.65%
CYP.AX 0.00%
DXB.AX 3.92%
ECS.AX 5.88%
EOF.AX -6.67%
GSS.AX 5.56%
IDT.AX -4.55%
IMC.AX -5.68%
IMM.AX 5.08%
IMU.AX -3.51%
IXC.AX 0.00%
KZA.AX 9.59%
LCT.AX 7.14%
LGP.AX 5.26%
MSB.AX 1.01%
MVP.AX -2.47%
MXC.AX 2.44%
NEU.AX -4.98%
NOX.AX 0.00%
NSB.AX 0.00%
OCC.AX 2.82%
OPT.AX -1.43%
OSL.AX 25.00%
PAA.AX 0.00%
PAB.AX 14.29%
PAR.AX 13.73%
PBP.AX 0.00%
PIQ.AX -1.14%
PTX.AX 5.26%
PXS.AX 3.70%
PYC.AX 0.00%
RAC.AX -0.27%
RCE.AX 5.26%
SPL.AX -3.16%
TLX.AX -3.00%
VBS.AX -1.30%
相関 (AI algo v.1.1b): Undervalued: 1.43% $0.355 paired level. (アルゴリズムは、最も相関の高い株式の変更をリアルタイムで追跡し、即時の更新を提供します)

ボリューム 相関

長: 0.08 (neutral)
短: 1.00 (very strong)
Signal:(55.561) Expect same movement, but be aware

Opthea Ltd 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Opthea Ltd 相関 - 通貨/商品

The country flag 0.48
( neutral )
The country flag 0.31
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Opthea Ltd 財務諸表

Annual 2023
収益: $161 163
総利益: $-89 309.00 (-55.42 %)
EPS: $-0.450
FY 2023
収益: $161 163
総利益: $-89 309.00 (-55.42 %)
EPS: $-0.450
FY 2022
収益: $125 047
総利益: $-107 422 (-85.91 %)
EPS: $-0.340
FY 2021
収益: $68 613.00
総利益: $0.00 (0.00 %)
EPS: $-0.195

Financial Reports:

No articles found.

Opthea Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Opthea Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.111 2004-10-11
Last Dividend $0.111 2004-10-11
Next Dividend $0 N/A
Payout Date 2004-11-01
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.111 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-07-01)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2004 $0.111 5.43%
2005 $0 0.00%
2006 $0 0.00%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
11 Oct 2004 $0.111 25 Aug 2004 15 Oct 2004 01 Nov 2004

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
EZL.AX Dividend Royal 2024-02-02 Semi-Annually 24 11.64% 8.24
GRR.AX Dividend Royal 2024-03-12 Semi-Annually 14 11.88% 7.99
RKN.AX Dividend Royal 2023-08-31 Annually 22 15.73% 7.24
TWR.AX Dividend King 2024-06-12 Annually 25 5.98% 7.21
YAL.AX Dividend Royal 2024-03-12 Annually 7 12.76% 7.18
SHM.AX Dividend Royal 2024-03-14 Semi-Annually 9 14.97% 7.14
HZN.AX Dividend Royal 2024-04-18 Semi-Annually 4 18.99% 7.06
BHP.AX Dividend Royal 2024-03-07 Semi-Annually 37 6.46% 6.97
CDD.AX Ex Dividend King 2024-05-24 Annually 21 91.43% 6.79
KSL.AX Dividend Royal 2024-03-05 Semi-Annually 9 9.58% 6.77

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1 383.771.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-1.4671.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM8.771.50010.0010.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM5.100.80010.008.00[1 - 3]
quickRatioTTM5.000.80010.008.00[0.8 - 2.5]
cashRatioTTM4.821.50010.0010.00[0.2 - 2]
debtRatioTTM0.000780-1.5009.99-10.00[0 - 0.6]
interestCoverageTTM-8.081.000-4.10-4.10[3 - 30]
operatingCashFlowPerShareTTM-0.3062.00-0.102-0.204[0 - 30]
freeCashFlowPerShareTTM-0.3062.00-0.153-0.306[0 - 20]
debtEquityRatioTTM-0.00277-1.500-0.01110.0166[0 - 2.5]
grossProfitMarginTTM-0.1691.000-6.15-6.15[0.2 - 0.8]
operatingProfitMarginTTM-1 413.431.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-1 397.121.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.001060.800-3.33-2.66[0.5 - 2]
Total Score-0.994

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.5611.000-0.1580[1 - 100]
returnOnEquityTTM8.772.5010.0010.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.3062.00-0.102-0.306[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.3062.00-0.102-0.204[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.05851.500-3.720[0.5 - 2]
operatingCashFlowSalesRatioTTM-1 027.631.000-10.000[0.1 - 0.5]
Total Score-0.615

Opthea Ltd Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Opthea Ltd

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。

Total Execution Time: 2.0578291416168 seconds
Number of API calls: 3
Number of DB calls: 9